An interview with: Jiafu Ji MD PhD DrPH FRCS, Fellow of the Chinese Academy of Medical Science, Professor and Chief, Gastrointestinal Cancer Center, Peking University Cancer Hospital, Beijing Institut
An interview with:
Jiafu Ji MD PhD DrPH FRCS, Fellow of the Chinese Academy of Medical Science, Professor and Chief, Gastrointestinal Cancer Center, Peking University Cancer Hospital, Beijing Institute for Cancer Research, Beijing, China
Sarah Maxwell, Audio Journal of Oncology:
The idea of harnessing two different pathways of checkpoint inhibition simultaneously is very appealing for the treatment of high-risk gastric cancers. But a research team in China, proposed that, blocking both the PD-1 and CTLA-4 pathways, within a single bi-specific agent, as a component of initial therapy, was potentially a better way to do this than to use a combination of two individual checkpoint inhibitors.
At the 2024 American Association for Cancer Research annual meeting in San Diego, Jiafu Ji, from the Beijing Institute for Cancer Research, reported his group’s findings from the COMPASSION-15 trial, with 610 patients who had untreated, unresectable, HER2-negative, locally advanced or metastatic gastric cancer, using the bi-specific agent, cadonilimab, together with standard chemotherapy. After his talk he discussed with us the rational for this approach and the promising clinical findings:
Jiafu Ji, MD, PhD, DrPh, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, the Beijing Key Laboratory of Carcinogenesis and Translational Research, and the Gastrointestinal Cancer Center, Beijing Cancer Hospital, Beijing, China
IN: “Gastric cancer is a leading cause of death in China………
OUT………American Association for Cancer Research, I’m Peter Goodwin”
10:13 secs
AACR ABSTRACT
Cadonilimab plus chemotherapy versus chemotherapy as first-line treatment for unresectable locally advanced or metastatic gastric or gastroesophageal junction (G/GEJ) adenocarcinoma (COMPASSION-15): A randomized, double-blind, phase 3 trial
Related Episodes
More Breast Cancer Cases in Younger Women since 2010 But Fewer Deaths
An interview with: Adetunji T. Toriola, MD, PhD, MPH, Professor of Surgery, Department of Surgery and Division of Public Health Sciences, Washington University School of Medicine and Siteman Cancer Ce
Fast, Accurate Artificial Intelligence Method to Diagnose and Classify Pediatric Sarcoma Anywhere
An interview with: Adam Thiesen, PhD Candidate, UConn Health, University of Connecticut and the Jackson Laboratory for Genomic Medicine, Farmington, CT And with: Jayesh Desai MD, Medical Oncologist,
Exosome Liquid Biopsy for Earliest Pancreatic Cancer Detection
An interview with: Ajay Goel PhD, Chair of the Molecular Diagnostics and Experimental Therapeutics Department, Beckman Research Institute, City of Hope, Los Angeles California. SAN DIEGO—The prospect